These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 20674215

  • 1. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A.
    J Pharm Biomed Anal; 2010 Dec 01; 53(4):997-1002. PubMed ID: 20674215
    [Abstract] [Full Text] [Related]

  • 2. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M, Di Stasio E, Basile MR, Elisei F, Antonini M, Ettorre GM, Iappelli M, Pucillo LP.
    Ther Drug Monit; 2013 Feb 01; 35(1):96-100. PubMed ID: 23191996
    [Abstract] [Full Text] [Related]

  • 3. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
    Saint-Marcoux F, Debord J, Parant F, Labalette M, Kamar N, Rostaing L, Rousseau A, Marquet P.
    Ther Drug Monit; 2011 Apr 01; 33(2):171-7. PubMed ID: 21383655
    [Abstract] [Full Text] [Related]

  • 4. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
    Toraishi T, Takeuchi H, Nakamura Y, Konno O, Yokoyama T, Iwamoto H, Hama K, Hirano T, Unezaki S, Okuyama K, Shimazu M.
    Transplant Proc; 2012 Jan 01; 44(1):134-6. PubMed ID: 22310597
    [Abstract] [Full Text] [Related]

  • 5. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS, Taylor PJ, Salm P, Morris RG.
    Ther Drug Monit; 2007 Oct 01; 29(5):584-91. PubMed ID: 17898648
    [Abstract] [Full Text] [Related]

  • 6. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
    Rostaing L, Cointault O, Marquet P, Josse AG, Lavit M, Saint-Marcoux F, Kamar N.
    Transpl Int; 2010 Feb 01; 23(2):227-30. PubMed ID: 19761555
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
    Marubashi S, Nagano H, Kobayashi S, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Monden M, Doki Y, Mori M.
    J Clin Pharmacol; 2010 Jun 01; 50(6):705-9. PubMed ID: 20097937
    [Abstract] [Full Text] [Related]

  • 8. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar 01; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.
    Moscato D, Nonnato A, Adamo R, Vancheri M, Caropreso A.
    Clin Chim Acta; 2010 Jan 01; 411(1-2):77-80. PubMed ID: 19835852
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer.
    Schmid RW, Lotz J, Schweigert R, Lackner K, Aimo G, Friese J, Rosiere T, Dickson D, Kenney D, Maine GT.
    Clin Biochem; 2009 Oct 01; 42(15):1543-8. PubMed ID: 19563794
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH, Yavuz A, Tuncer M, Yurdakonar E, Akcit F, Gurkan A, Demirbas A, Gultekin M, Ersoy F, Akaydin M.
    Transplant Proc; 2004 Oct 01; 36(1):86-8. PubMed ID: 15013308
    [Abstract] [Full Text] [Related]

  • 13. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
    Wallemacq P, Goffinet JS, O'Morchoe S, Rosiere T, Maine GT, Labalette M, Aimo G, Dickson D, Schmidt E, Schwinzer R, Schmid RW.
    Ther Drug Monit; 2009 Apr 01; 31(2):198-204. PubMed ID: 19258928
    [Abstract] [Full Text] [Related]

  • 14. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
    LeGatt DF, Shalapay CE, Cheng SB.
    Clin Biochem; 2004 Nov 01; 37(11):1022-30. PubMed ID: 15498532
    [Abstract] [Full Text] [Related]

  • 15. [Performance evaluation of affinity column mediated immunometric assay for tacrolimus].
    Chung JW, An D, Song J, Chung HJ, Park HI, Lee W, Chun S, Min WK.
    Korean J Lab Med; 2009 Oct 01; 29(5):415-22. PubMed ID: 19893350
    [Abstract] [Full Text] [Related]

  • 16. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
    Hashi S, Masuda S, Kikuchi M, Uesugi M, Yano I, Omura T, Yonezawa A, Fujimoto Y, Ogawa K, Kaido T, Uemoto S, Matsubara K.
    Transplant Proc; 2014 Apr 01; 46(3):758-60. PubMed ID: 24767342
    [Abstract] [Full Text] [Related]

  • 17. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH, Ozdem S, Caglar S, Tuncer M, Gurkan A, Yucetin L, Senol Y, Demirbas A, Gultekin M, Ersoy FF, Akaydin M.
    Clin Biochem; 2005 Jun 01; 38(6):552-7. PubMed ID: 15885236
    [Abstract] [Full Text] [Related]

  • 18. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK, Chang HK, Kim HJ, Huh KH, Ahn HJ, Kim MS, Kim SI, Kim YS.
    Transplant Proc; 2008 Dec 01; 40(10):3673-8. PubMed ID: 19100463
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the new heterogeneous ACMIA immunoassay for the determination of whole-blood cyclosporine concentrations in bone marrow, kidney, heart, and liver transplant recipients.
    Huet E, Morand K, Blanchet B, Astier A, Hulin A.
    Transplant Proc; 2004 Jun 01; 36(5):1317-20. PubMed ID: 15251322
    [Abstract] [Full Text] [Related]

  • 20. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results.
    Hermida J, Tutor JC.
    Ther Drug Monit; 2009 Apr 01; 31(2):269-72. PubMed ID: 19258927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.